Jefferies Financial Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Jefferies Financial Group’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-40,500	Closed	-$108K	–	1979
2024 Q1	$108K	Hold	40,500	–	–	﹤0.01%	1429
2023 Q4	$96K	Buy	40,500 +3,000	+8%	+$5.31K	﹤0.01%	1553
2023 Q3	$52.5K	Buy	+37,500	New	+$90.1K	﹤0.01%	1507

Jefferies Financial Group's KNTE Position: Q2 2024 in Review

Jefferies Financial Group sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 40,500 shares — an estimated $108K sold.

Jefferies Financial Group first reported a position in KNTE in Q3 2023 and held it in 3 quarters. The position peaked at $108K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Jefferies Financial Group reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jefferies Financial Group sold 40,500 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $108K.
Jefferies Financial Group first reported a position in Kinnate Biopharma Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Jefferies Financial Group's Kinnate Biopharma Inc. Common Stock position peaked at $108K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.